Who are Visine Dry Eye Relief eye drops's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Systane® Ultra, Hypromellose Eye Drop, Refresh Optive MEGA-3, Liquifilm artificial tears eyedrops.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/visine-dry-eye-relief-eye-drops.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Visine Dry Eye Relief eye drops — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Visine Dry Eye Relief eye drops (Visine Dry Eye Relief eye drops) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear lubricant. Area: Ophthalmology.

marketed Artificial tear lubricant Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Visine Dry Eye Relief eye drops (Visine Dry Eye Relief eye drops) — Massachusetts Eye and Ear Infirmary. Visine Dry Eye Relief lubricates and protects the ocular surface by providing artificial tears to supplement insufficient natural tear production.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Visine Dry Eye Relief eye drops TARGET	Visine Dry Eye Relief eye drops	Massachusetts Eye and Ear Infirmary	marketed	Artificial tear lubricant
Systane® Ultra	Systane® Ultra	The Mentholatum Company	marketed	Artificial tear lubricant
Hypromellose Eye Drop	Hypromellose Eye Drop	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	marketed	Artificial tear lubricant / Ophthalmic demulcent
Refresh Optive MEGA-3	Refresh Optive MEGA-3	Scripps Poway Eyecare and Optometry	marketed	Artificial tear lubricant / Ocular surface protectant
Liquifilm artificial tears eyedrops	Liquifilm artificial tears eyedrops	Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA	phase 3	Artificial tear lubricant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear lubricant class)

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA · 1 drug in this class
Massachusetts Eye and Ear Infirmary · 1 drug in this class
The Mentholatum Company · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Visine Dry Eye Relief eye drops — Competitive Intelligence Brief. https://druglandscape.com/ci/visine-dry-eye-relief-eye-drops. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab